|
The Parenteral Drug Association (PDA) is an international non-profit industry trade group for pharmaceutical and biopharmaceutical manufacturers. Founded in 1946 as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry, it now has more than 11,000 members worldwide. Today, coordinated through its headquarters and its Training & Research Institute in Bethesda, Maryland, PDA volunteers worldwide promote the exchange of rapidly evolving information on the latest technology and regulations concerning high-quality pharmaceutical production.〔(【引用サイトリンク】url=https://www.pda.org/footer/about-pda )〕 ==Global Organization== PDA has members in 74 countries: Africa Botswana, Egypt, Ghana, South Africa, Tunisia, Zimbabwe Asia Bangladesh, China, India, Pakistan Caribbean, Central, & South America Argentina, Brazil, Colombia, Costa Rica, Dominican Republic, Paraguay Peru, Uruguay Europe Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom Middle East Cyprus, Iran, Israel, Jordan, Saudi Arabia, Syria, Turkey, United Arab Emirates North America Canada, Mexico, Puerto Rico, United States Pacific-Rim Australia, Hong Kong, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand, Vietnam 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Parenteral Drug Association」の詳細全文を読む スポンサード リンク
|